[HTML][HTML] Radiation induced secondary malignancies: a review article

CB Dracham, A Shankar, R Madan - Radiation oncology journal, 2018 - ncbi.nlm.nih.gov
Radiation-induced second malignancies (RISM) is one of the important late side effects of
radiation therapy and has an impact on optimal treatment decision-making. Many factors …

A critical review of radiation therapy: from particle beam therapy (proton, carbon, and BNCT) to beyond

Y Matsumoto, N Fukumitsu, H Ishikawa… - Journal of personalized …, 2021 - mdpi.com
In this paper, we discuss the role of particle therapy—a novel radiation therapy (RT) that has
shown rapid progress and widespread use in recent years—in multidisciplinary treatment …

National Cancer Institute workshop on proton therapy for children: considerations regarding brainstem injury

D Haas-Kogan, D Indelicato, H Paganetti… - International Journal of …, 2018 - Elsevier
Purpose Proton therapy can allow for superior avoidance of normal tissues. A widespread
consensus has been reached that proton therapy should be used for patients with curable …

Future cancer research priorities in the USA: a Lancet Oncology Commission

EM Jaffee, C Van Dang, DB Agus… - The Lancet …, 2017 - thelancet.com
We are in the midst of a technological revolution that is providing new insights into human
biology and cancer. In this era of big data, we are amassing large amounts of information …

Proton versus photon radiation therapy: A clinical review

Z Chen, MM Dominello, MC Joiner… - Frontiers in …, 2023 - frontiersin.org
While proton radiation therapy offers substantially better dose distribution characteristics
than photon radiation therapy in certain clinical applications, data demonstrating a …

Paediatric proton therapy

H Thomas, B Timmermann - The British journal of radiology, 2020 - academic.oup.com
Proton beam therapy is a highly conformal form of radiation therapy, which currently
represents an important therapeutic component in multidisciplinary management in …

New developments in the pathogenesis, therapeutic targeting, and treatment of pediatric medulloblastoma

FY Fang, JS Rosenblum, WS Ho, JD Heiss - Cancers, 2022 - mdpi.com
Simple Summary Medulloblastoma is the most common pediatric brain tumor, comprising
one-third of all pediatric brain tumors, and originating in the posterior fossa of the brain. The …

Simvastatin induces apoptosis in medulloblastoma brain tumor cells via mevalonate cascade prenylation substrates

K Sheikholeslami, A Ali Sher, S Lockman, D Kroft… - Cancers, 2019 - mdpi.com
Medulloblastoma is a common pediatric brain tumor and one of the main types of solid
cancers in children below the age of 10. Recently, cholesterol-lowering “statin” drugs have …

Secondary malignancy risk following proton radiation therapy

BR Eaton, SM MacDonald, TI Yock, NJ Tarbell - Frontiers in oncology, 2015 - frontiersin.org
Radiation-induced secondary malignancies are a significant, yet uncommon cause of
morbidity and mortality among cancer survivors. Secondary malignancy risk is dependent …

Progression‐free survival of children with localized ependymoma treated with intensity‐modulated radiation therapy or proton‐beam radiation therapy

M Sato, JR Gunther, A Mahajan, E Jo, AC Paulino… - Cancer, 2017 - Wiley Online Library
BACKGROUND The treatment for childhood intracranial ependymoma includes maximal
surgical resection followed by involved‐field radiotherapy, commonly in the form of intensity …